The 3rd Annual CRISPR & Precision Genome Editing Congress Boston 2017 will enhance the basic research, drug discovery and therapeutic applications of CRISPR technology by overcoming key specificity, efficiency and delivery challenges needed to improve the precise editing and repair of the genome.
Join the leading CRISPR figureheads as they reveal advanced methodology, strategies and clinical timelines that maximize the power of precision genome editing and fulfill its revolutionary potential.
"This is designed to describe the profound impact CRISPR is having on basic research and therapeutic development. It will explore what's needed to make the most of this breakthrough technology." Eric Rhodes, Horizon